Beijing WellGene Biotech Co., Ltd.
PrivateLast Round
Series C
May 22, 2023
Total Funding Raised
$58.01M
Company Overview
Beijing WellGene Biotech Co., Ltd. is a biotechnology company that develops gene therapy drugs and oncolytic virus therapies for the treatment of tumors, skin diseases, and other rare or refractory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing WellGene Biotech Co., Ltd. Comparables
Compare Beijing WellGene Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmVira | 85% | |
| Virogin Biotech | 85% | |
| Wuhan Binhui Biopharmaceutical Co., Ltd. | 81% |
Beijing WellGene Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 22, 2023 | ||||
| Series B | Nov 1, 2020 | ||||
| Series A | Sep 1, 2019 |
Beijing WellGene Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fengchuan Capital | Series B, Series C |
| Shanghai Science and Technology Innovation Group | Series C |
| Beijing Zhongguancun Science City Innovation Development Co., Ltd. | Series C |
| SDIC Venture Capital | Series C, Series B |
| Guangdong Shunde Kechuang Management Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2020
$15.15M round led by SDIC Venture Capital
- Sep 1, 2019
Completed a Series A funding round.
Beijing WellGene Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing WellGene Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Beijing WellGene Biotech Co., Ltd. a public or private company?
Beijing WellGene Biotech Co., Ltd. is a private company.
What is the current stock price of Beijing WellGene Biotech Co., Ltd.?
Beijing WellGene Biotech Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Beijing WellGene Biotech Co., Ltd. worth (valuation)?
Valuation information for Beijing WellGene Biotech Co., Ltd. is not publicly available.
Can I buy Beijing WellGene Biotech Co., Ltd. stock?
Beijing WellGene Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing WellGene Biotech Co., Ltd.'s last funding round?
Beijing WellGene Biotech Co., Ltd.'s most recent funding round was Series C on May 22, 2023.
Who are the main investors in Beijing WellGene Biotech Co., Ltd.?
Key investors in Beijing WellGene Biotech Co., Ltd. include SDIC Venture Capital.
Will Beijing WellGene Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing WellGene Biotech Co., Ltd..
How can I track Beijing WellGene Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing WellGene Biotech Co., Ltd.'s secondary market activity and sign up for updates.